Atlas market file · Equity · United States
BGM Group Ltd.BGM
- Last close
- 0.2961
- Change
- -0.30%
- 96-bar range
- 0.25 – 1.08
- As of
- 6 Aug 2026
BGM Group Ltd. is a pharmaceutical preparations issuer listed as BGM on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
BGM
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-94.95% over the window).
Source rail: Yahoo Finance chart API (BGM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for BGM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
BGM public profile
Pharmaceutical preparations issuer. BGM Group Ltd. is connected to current market context, cited company sources and its retained research file.
BGM Group Ltd. trades as BGM on NASDAQ. BGM Group Ltd. (BGM) has a latest verified close of 0.2961, down 0.30%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files BGM under USA Stocks for browsing.
What changed for BGM Group Ltd. today
BGM Group Ltd. (NASDAQ: BGM) reported a net loss of $19.9M for the year ended September 30, 2025, despite touting a $1 billion AI platform acquisition in late 2024. The company’s cash reserves stood at just $9.8M, while inventory increased to $20.1M, raising questions about liquidity and asset utilization. (source: BGM 20-F)
BGM operates through Chinese subsidiaries, including Rugao Tianlu Animal Products Co. and Zhongqiao Youguan, with its financial health tied to dividends from these entities. The company’s SEC filings highlight 'holistic integration of healthcare and insurtech,' though its core business remains opaque, backed by declining operating cash flow of -$2.4M. (source: BGM 20-F)
Recent filings disclose a board reshuffle in February 2025, adding executives with automotive AI experience, and a 1-for-5 reverse share split in May 2026. These moves follow years of negative net income and thin operating margins, with R&D spending lagging at $672,669. (source: BGM 6-K, BGM News)
Chart watchers note BGM’s share price has traded below $5 since 2023, despite the reverse split. The stock’s average daily volume remains low, reflecting limited institutional interest. No major catalysts are evident from filings to reverse the cash burn or inventory buildup. (source: TradingView)
The company’s ability to fund operations hinges on subsidiary performance, particularly in animal products and e-commerce services. However, its diluted EPS of -$0.18 and 113.3M shares outstanding signal ongoing pressure from share dilution and weak profitability. (source: BGM 20-F)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
BGM technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on BGM
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep BGM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
BGM FAQ
What is BGM Group Ltd. (BGM)?BGM Group Ltd. (BGM) has a latest verified close of 0.2961, down 0.30%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
BGM Group Ltd. (BGM) has a latest verified close of 0.2961, down 0.30%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for BGM?BGM Group Ltd. (BGM) has a latest verified close of 0.2961, down 0.30%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
BGM Group Ltd. (BGM) has a latest verified close of 0.2961, down 0.30%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files BGM under USA Stocks for browsing.
How often is the BGM page updated?The BGM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The BGM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for BGM?The BGM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BGM. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The BGM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BGM. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on BGM?Yes. The workstation can open BGM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open BGM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this BGM page investment advice?No. The BGM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The BGM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →